Bedinvetmab, sold under the brand name Librela, is a canine monoclonal antibody used for the control of pain associated with osteoarthritis in dogs. Librela is sponsored by Zoetis. From Wikipedia
The medication, approved in 2023 to treat osteoarthritis in dogs, has been associated with thousands of health issues and fatalities, prompting an official alert to veterinarians.
